BMJ, doi: 10.1136/bmj.38764.572569.7C, (Published 3 March 2006)

RESEARCH

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

Sophia Zackrisson ^1*, Ingvar Andersson ², Lars Janzon ¹, Jonas Manjer ¹, Jens Peter Garne ³

¹ Department of Clinical Sciences in Malmö, Epidemiological Research Group, Lund University, Malmö University Hospital, SE-205 02, Malmö, Sweden
² Medical Radiology, Malmö University Hospital
³ Department of Surgery, Aarhus University Hospital, DK 8000 Århus C, Denmark

^* Correspondence to: sophia.zackrisson{at}med.lu.se.

Objective To evaluate the rate of over-diagnosis of breast cancer 15 years after the end of the Malmö mammographic screening trial.

Design Follow-up study.

Setting Malmö, Sweden.

Subjects 42 283 women aged 45-69 years at randomisation.

Interventions Screening for breast cancer with mammography or not (controls). Screening was offered at the end of the randomisation design to both groups aged 45-54 at randomisation but not to groups aged 55-69 at randomisation.

Main outcome measures Rate of over-diagnosis of breast cancer (in situ and invasive), calculated as incidence in the invited and control groups, during period of randomised design (period 1), during period after randomised design ended (period 2), and at end of follow-up.

Results In women aged 55-69 years at randomisation the relative rates of over-diagnosis of breast cancer (95% confidence intervals) were 1.32 (1.14 to 1.53) for period 1, 0.92 (0.79 to 1.06) for period 2, and 1.10 (0.99 to 1.22) at the end of follow-up.

Conclusion Conclusions on over-diagnosis of breast cancer in the Malmö mammographic screening trial can be drawn mainly for women aged 55-69 years at randomisation whose control groups were never screened. Fifteen years after the trial ended the rate of over-diagnosis of breast cancer was 10% in this age group.

---

(Accepted 27 January 2006)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Participation in mammography screening

Lisa M Schwartz and Steven Woloshin
BMJ 2007 335: 731-732. [Extract] [Full Text] [PDF]

Breast cancer screening yields 10% over-diagnosis
BMJ 2006 332: 0. [Full Text]

Count the harms

Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

Evaluating new screening tests for breast cancer

Les Irwig, Nehmat Houssami, Bruce Armstrong, and Paul Glasziou
BMJ 2006 332: 678-679. [Extract] [Full Text] [PDF]

Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers

H Gilbert Welch, Lisa M Schwartz, and Steven Woloshin
BMJ 2006 332: 727. [Extract] [Full Text] [PDF]

Ramifications of screening for breast cancer: Overdiagnosis in the Malmö trial was considerably underestimated

Peter C Gøtzsche
BMJ 2006 332: 727. [Extract] [Full Text]

Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmö trial

Per-Henrik Zahl and Jan Mæhlen
BMJ 2006 332: 727-728. [Extract] [Full Text]

Ramifications of screening for breast cancer: Consent for screening

Michael Baum
BMJ 2006 332: 728. [Extract] [Full Text]

Ramifications of screening for breast cancer: More debate and better information still needed

Hazel Thornton
BMJ 2006 332: 728. [Extract] [Full Text]

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

Per-Henrik Zahl, Bjørn Heine Strand, and Jan Mæhlen
BMJ 2004 328: 921-924. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Hofvind, S., Vacek, P. M., Skelly, J., Weaver, D. L., Geller, B. M. (2008). Comparing Screening Mammography for Early Breast Cancer Detection in Vermont and Norway. JNCI J Natl Cancer Inst 100: 1082-1091 [Abstract] [Full text]  
• Welch, H. G., Woloshin, S., Schwartz, L. M. (2008). The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography. JNCI J Natl Cancer Inst 100: 228-229 [Full text]  
• Welch, H. G., Woloshin, S., Schwartz, L. M., Gordis, L., Gotzsche, P. C., Harris, R., Kramer, B. S., Ransohoff, D. F. (2007). Overstating the Evidence for Lung Cancer Screening: The International Early Lung Cancer Action Program (I-ELCAP) Study. Arch Intern Med 167: 2289-2295 [Abstract] [Full text]  
• Schwartz, L. M, Woloshin, S. (2007). Participation in mammography screening. BMJ 335: 731-732 [Full text]  
• Vanhems, P., Pires-Cronenberger, S., Lasset, C. (2007). Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 30: 813-813 [Full text]  
• Eisinger, F. (2007). Phenocopies: actual risk or self-fulfilling prophecy?. J. Med. Genet. 44: e87-e87 [Full text]  
• Glass, A. G., Lacey, J. V. Jr, Carreon, J. D., Hoover, R. N. (2007). Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status. JNCI J Natl Cancer Inst 99: 1152-1161 [Abstract] [Full text]  
• Berry, D. A., Ravdin, P. M. (2007). Breast Cancer Trends: A Marriage Between Clinical Trial Evidence and Epidemiology. JNCI J Natl Cancer Inst 99: 1139-1141 [Full text]  
• Irwig, L., Houssami, N., Armstrong, B., Glasziou, P. (2006). Evaluating new screening tests for breast cancer.. BMJ 332: 678-679 [Full text]  
• Welch, H G., Schwartz, L. M, Woloshin, S. (2006). Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.. BMJ 332: 727-727 [Full text]  
• Baum, M. (2006). Ramifications of screening for breast cancer: consent for screening.. BMJ 332: 728-728 [Full text]  
• Gotzsche, P. C (2006). Ramifications of screening for breast cancer: overdiagnosis in the Malmo trial was considerably underestimated.. BMJ 332: 727-727 [Full text]  
• Zahl, P.-H., Maehlen, J. (2006). Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmo trial.. BMJ 332: 727-728 [Full text]  
• Thornton, H. (2006). Ramifications of screening for breast cancer: more debate and better information still needed.. BMJ 332: 728-728 [Full text]  
• Moller, H., Davies, E. (2006). Over-diagnosis in breast cancer screening. BMJ 332: 691-692 [Full text]  

Rapid Responses:

Read all Rapid Responses

A confusing definition of overdiagnosis

Per-Henrik Zahl, et al.
bmj.com, 7 Mar 2006 [Full text]

How much overdiagnosis?

H. Gilbert Welch
bmj.com, 10 Mar 2006 [Full text]

Overdiagnosis in the Malmö mammography screening trial was considerably underestimated

Peter C Gøtzsche
bmj.com, 16 Mar 2006 [Full text]

1 in 4 Cancers detected by mammography are pseudocancers

H. Gilbert Welch
bmj.com, 20 Mar 2006 [Full text]

Quantification of overdiagnosis : simple solutions are not necessarily true

Eugenio Paci, et al.
bmj.com, 15 Apr 2006 [Full text]